Loading clinical trials...
Loading clinical trials...
Randomized, Placebo-controlled Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression (DEXAD)
Conditions
Interventions
DEX IR tablets
DEX XL
+1 more
Locations
2
Germany
Department of Psychiatry, Psychosomatics and Psychotherapy University Hospital Frankfurt am Main - Goethe University
Frankfurt, Germany
University Leipzig, Department of Psychiatry and Psychotherapy
Leipzig, Germany
Start Date
May 15, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
January 13, 2026
NCT06793397
NCT07422519
NCT06878859
NCT07424781
NCT07404085
NCT07250893
Lead Sponsor
Prof. Dr. Frank Behrens
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions